Compound ID | 1446

Update compound information

IMX 942

Synonym(s): Dusquetide

Spectrum of activity: Gram-negative
Details of activity: Useful against Nosocomial infections and Gram-negative bacteria
Institute where first reported: Soligenix
Year first mentioned: 2009
Highest development stage: Preclinical
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 553.7
Iso. SMILES: CC[C@H](C)C(C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N)NC(=O)[C@H](CCCN=C(N)N)N
InChI Key: ZUJBBVJXXYRPFS-OUROWQTJSA-N
Can. SMILES: CC[C@H](C)C(C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N)NC(=O)[C@H](CCCN=C(N)N)N
InChI: InChI=1S/C25H47N9O5/c1-6-14(4)19(33-21(36)16(26)9-7-11-30-25(28)29)23(38)32-18(13(2)3)24(39)34-12-8-10-17(34)22(37)31-15(5)20(27)35/h13-19H,6-12,26H2,1-5H3,(H2,27,35)(H,31,37)(H,32,38)(H,33,36)(H4,28,29,30)/t14-,15-,16-,17-,18-,19?/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/122177130
Guide to Pharmacology: dusquetide
Citations:
  • https://adisinsight.springer.com/drugs/800030132
  • https://www.soligenix.com/wp-content/uploads/2019/05/Reduced-Infection-and-Mucositis-in-Chemotherapy-Treated-Animals-Following-Innate-Defense-Modulation-Using-a-Novel-Drug-Candidate.pdf
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418506/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.